Polysilicone base for scar treatment
US9226890B1 · kind B1 · utility
4Cited by
79References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 9, 2014 |
| Grant date | Jan 5, 2016 |
| Priority date | — |
| Expiry date | Dec 9, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2400/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A polysilicone base for medical and cosmetic compositions includes a dimethicone fluid, a volatile cyclosiloxane, a silicone elastomer, and nanoparticulate silica. The polysilicone base may also include one or more therapeutic agents for reducing the formation and appearance of scar tissue at the site of a wound. The polysilicone base is spreadable, but does not run off of the wound site. The polysilicone base is phase-stable, in that it does not separate into phases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.